The company was approved as "recombinant protein drug engineering research center" by chongqing deve
Category: Company news
Date: 2011-03-06
Click: 974
Author: kerun

1559529183921094662.jpg

      In 2011, the company was named as the municipal "recombinant protein drug engineering research center" in the innovation foundation project and special project of chongqing development and reform commission, which further improved and expanded the technical advantages of the platform.

Previous: Leaders of tianjin science and technology commission visited korun
Next: The "11th five-year plan" national "biotechnology new drug pilot test amplification, isolation and p